• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    MannKind Initiates Phase 3 Trial in Australia for NTM Lung Disease

    GLOBENEWSWIRE

    MannKind To Start Phase 3 NTM Trial In Japan

    GLOBENEWSWIRE

    MannKind`s Clofazimine Gets FDA Fast Track For NTM Lung Disease

    GLOBENEWSWIRE

    MannKind Gets IND Clearance for Ph3 Clofazimine in NTM Lung Disease

    GLOBENEWSWIRE

    Midas Pharma obtains CEP for Clofazimine

    PRESS RELEASE

    Could this low-cost leprosy drug be repurposed for COVID-19?

    FIERCEBIOTECH

    MannKind Expands Its Pipeline with the Acquisition of QrumPharma, Inc.Lead

    BIOSPACE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.